← Back to Search

Acoustic Resonance Therapy for Stuffy Nose

N/A
Recruiting
Led By Jacob Johnson, MD
Research Sponsored by Third Wave Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age and older
Present with symptoms of chronic nasal congestion
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial showed Acoustic Resonance Therapy may help reduce nasal congestion symptoms.

Who is the study for?
This study is for adults over 18 with chronic nasal congestion, scoring at least 2 out of 3 on a specific stuffy nose scale. It's not suitable for those who've had head, nasal or sinus surgery within the last three months or are pregnant.
What is being tested?
The trial is testing Sonu Acoustic Resonance Therapy to see how well it works in real-world settings for relieving moderate to severe nasal congestion symptoms.
What are the potential side effects?
Potential side effects aren't specified here, but similar therapies may cause discomfort in the ears or sinuses, headache, or temporary hearing changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have long-term nasal congestion.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Weekly Utilization-Duration
Weekly Utilization-Frequency
Secondary study objectives
Asthma Control
Total Nasal Symptom Score (TNSS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionalExperimental Treatment1 Intervention
Participants will receive Acoustic Resonance Therapy using the Sonu headband and App, twice a day, for 90 days

Find a Location

Who is running the clinical trial?

Third Wave TherapeuticsLead Sponsor
3 Previous Clinical Trials
127 Total Patients Enrolled
Jacob Johnson, MDPrincipal InvestigatorSan Francisco Otolaryngology Medical Group
4 Previous Clinical Trials
143 Total Patients Enrolled
~107 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top